Routh, J. C., Kramer, S. A., Inman, B. A., Ashley, R. A., Wolpert, J. J., Vandersteen, D. R., … Reinberg, Y. (2007). 519: Bladder and Ureteral Anomalies do not Reduce the Efficacy of Dextranomerihyaluronic Acid for Vesicoureteral Reflux. In Journal of Urology (Vol. 177, pp. 173–173). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1016/s0022-5347(18)30759-6

Routh, Jonathan C., Stephen A. Kramer, Brant A. Inman, Richard A. Ashley, James J. Wolpert, David R. Vandersteen, Douglas A. Husmann, and Yuri Reinberg. “519: Bladder and Ureteral Anomalies do not Reduce the Efficacy of Dextranomerihyaluronic Acid for Vesicoureteral Reflux.” In Journal of Urology, 177:173–173. Ovid Technologies (Wolters Kluwer Health), 2007. https://doi.org/10.1016/s0022-5347(18)30759-6.

Routh JC, Kramer SA, Inman BA, Ashley RA, Wolpert JJ, Vandersteen DR, et al. 519: Bladder and Ureteral Anomalies do not Reduce the Efficacy of Dextranomerihyaluronic Acid for Vesicoureteral Reflux. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 173–173.

Routh, Jonathan C., et al. “519: Bladder and Ureteral Anomalies do not Reduce the Efficacy of Dextranomerihyaluronic Acid for Vesicoureteral Reflux.” Journal of Urology, vol. 177, no. 4S, Ovid Technologies (Wolters Kluwer Health), 2007, pp. 173–173. Crossref, doi:10.1016/s0022-5347(18)30759-6.

Routh JC, Kramer SA, Inman BA, Ashley RA, Wolpert JJ, Vandersteen DR, Husmann DA, Reinberg Y. 519: Bladder and Ureteral Anomalies do not Reduce the Efficacy of Dextranomerihyaluronic Acid for Vesicoureteral Reflux. Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 173–173.